183 related articles for article (PubMed ID: 38292874)
1. Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression
Smekalova EM; Martinez MG; Combe E; Kumar A; Dejene S; Leboeuf D; Chen CY; Dorkin JR; Shuang LS; Kieft S; Young L; Barrera LA; Packer MS; Ciaramella G; Testoni B; Gregoire F; Zoulim F
Mol Ther Nucleic Acids; 2024 Mar; 35(1):102112. PubMed ID: 38292874
[TBL] [Abstract][Full Text] [Related]
2.
Tu T; Zehnder B; Qu B; Urban S
JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
[TBL] [Abstract][Full Text] [Related]
3. Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing.
Zhou H; Wang X; Steer CJ; Song G; Niu J
Hepatol Commun; 2022 Jul; 6(7):1652-1663. PubMed ID: 35338607
[TBL] [Abstract][Full Text] [Related]
4. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models.
Yi J; Lei X; Guo F; Chen Q; Chen X; Zhao K; Zhu C; Cheng X; Lin J; Yin H; Xia Y
Antiviral Res; 2023 Jul; 215():105618. PubMed ID: 37142191
[TBL] [Abstract][Full Text] [Related]
6. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
J Virol; 2018 May; 92(10):. PubMed ID: 29491161
[TBL] [Abstract][Full Text] [Related]
7. Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo.
Gorsuch CL; Nemec P; Yu M; Xu S; Han D; Smith J; Lape J; van Buuren N; Ramirez R; Muench RC; Holdorf MM; Feierbach B; Falls G; Holt J; Shoop W; Sevigny E; Karriker F; Brown RV; Joshi A; Goodwin T; Tam YK; Lin PJC; Semple SC; Leatherbury N; Delaney Iv WE; Jantz D; Rhoden Smith A
Mol Ther; 2022 Sep; 30(9):2909-2922. PubMed ID: 35581938
[TBL] [Abstract][Full Text] [Related]
8. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas.
Yang YC; Yang HC
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062208
[TBL] [Abstract][Full Text] [Related]
9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
10. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
Qu B; Nebioglu F; Leuthold MM; Ni Y; Mutz P; Beneke J; Erfle H; Vondran FWR; Bartenschlager R; Urban S
JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
[TBL] [Abstract][Full Text] [Related]
11. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
[TBL] [Abstract][Full Text] [Related]
14. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Gene Therapy Coming to Age.
Soriano V
AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
[TBL] [Abstract][Full Text] [Related]
16. NgAgo-gDNA system efficiently suppresses hepatitis B virus replication through accelerating decay of pregenomic RNA.
Wu Z; Tan S; Xu L; Gao L; Zhu H; Ma C; Liang X
Antiviral Res; 2017 Sep; 145():20-23. PubMed ID: 28709658
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants.
Martinez MG; Combe E; Inchauspe A; Mangeot PE; Delberghe E; Chapus F; Neveu G; Alam A; Carter K; Testoni B; Zoulim F
mBio; 2022 Apr; 13(2):e0288821. PubMed ID: 35389262
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
Malmström S; Larsson SB; Hannoun C; Lindh M
PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
[TBL] [Abstract][Full Text] [Related]
19. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
20. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]